Pfizer adult RSV vaccine efficacy declines barely after 18 months
Pfizer's vaccine that protects adults ages 60 and older from respiratory syncytial virus was barely less effective after 18 months, ...
Pfizer's vaccine that protects adults ages 60 and older from respiratory syncytial virus was barely less effective after 18 months, ...